Shandong Lukang Pharmaceutical Funds RMB 3 Billion Biomedical Industrial Park
This article was originally published in PharmAsia News
Executive Summary
According to an agreement signed between Zoucheng city municipal government and Hualu Holdings, Shandong Lukang Pharmaceutical Group will invest RMB 3 billion to begin construction on a biomedical industrial park this year